MedTrace Logo

Walking in Pregnancy and Prevention of Insomnia in Third Trimester Using Pedometers

NCT03735381 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2019-09-26

No results posted yet for this study

Summary

Randomized Control Trial (RCT), were healthy but sedentary women are selected in their first trimester of pregnancy. This RCT has two interventions arms (pedometer plus a goal of 11,000 steps / day and pedometer without goal) and a control group arm, without the use of pedometer. The main objective is to promote physical activity in pregnancy decreasing the prevalence of insomina at their third trimester of pregnancy.

Conditions

Interventions

DEVICE

Pedometer watch 'Xiomi mi band2'

1. They receive information on the use of the pedometer. 2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW. 3. Prescription of benefits of walking in pregnancy: * Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group). * Receive information on the adequacy of walking with moderate intensity. 4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Carmen Amezcua Prieto · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-02
Primary Completion
2019-12-15
Completion
2020-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03735381 on ClinicalTrials.gov